INTRODUCTION
Cell migration is not only a central feature of a range of physiological processes, but also a crucial event in the spread of cancer and, consequently, the metastatic process. 1 Ras protein, a guanine nucleotide (GTP) binding protein, has an important role in signal transduction and regulation of cell migration. 2, 3 A series of posttranslational modifications are essential for the cell membrane association of Ras protein. One key modification is farnesylation of Ras by farnesyl transferase (FTase) on the C-terminus cystein residue of the CAAX motif. 4 Previously, we screened for inhibitors of cancer cell migration and obtained moverastin A and B, new members of the cylindrol family, from Aspergillus sp. F7720. 5 Furthermore, we found that moverastin A and B inhibited FTase, and demonstrated that moverastins inhibited the migration of tumor cells by inhibiting the farnesylation of H-Ras. However, the inhibitory activity of moverastins for FTase was rather modest (IC 50 value of 14.7 mM). Thus we started screening of potent inhibitors of FTase as part of the project in Screening Committee of Anticancer Drugs (SCADS). In this study, we found new inhibitors of FTase, N-benzyl-aclacinomycin A (ACM) and N-allyl-ACM, which are chemically synthesized derivatives of ACM (aclarubicin) and described the antimigrative effect of these compounds.
MATERIALS AND METHODS

General experimental procedures
Centrifugal partition chromatography was performed using a centrifugal partition chromatograph-L.L.N. (Model-NMF, 250 ml cell; Sanki Engineering, Tokyo, Japan). HRMS were recorded on an Accu TOF-T100LC (JEOL, Tokyo, Japan) mass spectrometer. 1 H-NMR and 13 C-NMR data were measured on a JEOL ECX-600 spectrometer. Chemical shifts for proton are reported in p.p.m. downfield from tetramethylsilane. For 13 C NMR, chemical shifts were reported in the scale relative to NMR solvent (CDCl 3 : 77.0 p.p.m.) as an internal reference. Optical rotations were measured with a P-1030 polarimeter (JASCO, Tokyo, Japan). IR spectra were recorded on a FT/IR-4100 Fourier transform IR spectrometer (JASCO).
Preparation of N-benzyl-ACM
ACM hydrochloride (255.9 mg, 0.301 mM) in dry dimethylformamide (5.2 ml) was treated with benzyl bromide (0.108 ml, 3.0 equiv.) in the presence of diisopropylethylamine (0.315 ml, 6.0 equiv.) at room temperature for 19 h. After removal of the solvent, the residue was dissolved in CHCl 3 , washed with H 2 O and then continuously with aqueous Na 2 SO 4 . The CHCl 3 layer was dried over Na 2 SO 4 and evaporated. The oily residue was washed with hexane-diethyl ether (4:1) three times and the remaining residue (crude material 1) (328.4 mg) was purified by centrifugal partition chromatography ( Table 1 .
In vitro FTase assay
In vitro FTase assay was carried out according to the procedures previously described. 5 In brief, the standard reaction mixture of FTase contained the following components in a final volume of 60 ml:10 mg of partially purified FTase from human esophageal tumor EC17 cells, 10 mg of recombinant GST-H-Ras protein, 0.06 mM of ( 3 H)-farnesyl pyrophosphate (FPP) (596 GBq mmol À1 ; New England Nuclear, Boston, MA, USA), 50 mM Tris-HCl (pH 7.5, Sigma, St Louis, MO, USA), 50 mM ZnCl 2 (Kanto Chemical Co., Tokyo, Japan), 4 mM MgCl 2 (Wako Pure Chemical Industries Ltd, Osaka, Japan) and 4 mM DTT (Wako). The reaction was initiated by the addition of enzyme and incubated for 1 h at 37 1C. The reaction was stopped by the addition of 0.5 ml of 1% sodium dodecyl sulfate (SDS, Wako) in MeOH and 0.5 ml of 30% trichloroacetic acid (TCA, Wako). The mixture was then filtered through a Whatman GF/C filter (GE Healthcare, Buckinghamshire, UK), washed with 5 ml of 6% TCA. The dried filter was finally placed in a liquid scintillation counter (Beckman Coulter, Inc., Miami, FL, USA). A blank value was determined in a parallel incubation with boiled enzymes and was subtracted before calculating percent inhibition.
Detection of H-Ras translocation to plasma membrane
Human epidermoid carcinoma A431 cells (1 Â 10 6 ) were seeded in 10 cm dishes and cultured overnight. After the culture supernatant was replaced with DMEM (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 0.2% calf serum, the cells were pretreated with drugs for 15 min and stimulated with 30 ngml À1 epidermal growth factor (EGF, Sigma). Following 24 h of incubation, cells were collected and resuspended in buffer A (20 mM Hepes (Sigma), pH 7.5, 10 mM KCl (Kanto Chemical), 1.5 mM MgCl 2 , 1mM EDTA (Kanto Chemical), 1 mM EGTA (Wako) and 1 mM DTT containing 250 mM sucrose (Sigma) and 1 mM phenylmethylsulfonyl fluoride (PMSF, Sigma). The cells were homogenized and unbroken cells were removed by centrifuging the homogenates at 1,000 Â g for 10 min at 41C. The supernatant was centrifuged at 100 000 Â g for 1 h at 4 1C. The supernatant was removed and the pellets were lysed in radioimmunoprecipitation assay buffer buffer (25 mM Hepes, 1.5% Triton X-100 (Wako), 1% sodium deoxycholate (Wako), 0.1% SDS, 0.5 M NaCl (Wako), 5 mM EDTA, 50 mM NaF (Sigma), 0.1 mM sodium vanadate (Sigma) and 1 mM PMSF, pH 7.8) with sonication. The lysates were centrifuged at 100 000 Â g for 15 min at 4 1C to give the plasma membrane fraction. The cells were also directly lysed in radioimmunoprecipitation assay buffer buffer with sonication, and the resultant samples were used as the total cell lysate. All samples were subjected to western blotting to detect H-Ras protein.
Transwell migration assay
Cell migration was assayed with a chemotaxis chamber (Becton Dickinson, Franklin Lakes, NJ, USA). A431 cells (7.5 Â 10 4 ) suspended in DMEM supplemented with 0.2% calf serum were incubated in the upper chamber; the lower chamber contained DMEM supplemented with 0.2% calf serum in the presence or the absence of EGF (30 ngml À1 ). Drugs were added to both chambers. Following 24 h of incubation, the filter was fixed with MeOH and stained with hematoxylin (Sigma). The cells attached to the lower side of the filter were counted.
RESULTS AND DISCUSSION
Screening for inhibitors of FTase
We evaluated the inhibitory activity of compounds against FTase in the project of the SCADS. SCADS is offering several biological activity evaluation of synthesized or isolated compounds for Japanese chemists. For the in vitro FTase assay, FTase was partially purified from human esophageal tumor EC17 cells and recombinant GST-HRas and ( 3 H)-FPP were used as the substrates. We firstly investigated the effect of compounds on FTase activity at the concentration of 10 mM. As a result, two compounds were found to have inhibitory activity against FTase. As shown in Figure 1 , these are novel derivatives of ACM, and were named N-benzyl-ACM and N-allyl-ACM, respectively. ACM was discovered from a culture of Streptomyces galilaeus, and it showed potent antitumor activity. 6, 7 Effect of N-benzyl-ACM and N-allyl-ACM on FTase activity In the next step, we examined the inhibitory activities of these ACM derivatives to give IC 50 values. As shown in Figure 2 , N-benzyl-ACM and N-allyl-ACM inhibit FTase activity in a dose-dependent manner, and the IC 50 values of N-benzyl-ACM and N-allyl-ACM were 0.86 and 2.93 mM, respectively (Table 2) . On the other hand, ACM did not inhibit FTase activity at a concentration of 10 mM in the process of the screening project of SCADS. Interestingly, neither the C-10 epimer of N-benzyl-ACM (10-epi-N-benzyl-ACM, see Supplementary Information) nor the C-10 epimer of N-allyl-ACM (10-epi-N-allyl-ACM, see Supplementary Information) showed an inhibitory effect against FTase activity at a concentration of 10 mM. These results indicated that both modification of the N-dimethyl group and the configuration of C-10 are critical for the inhibitory activity of N-benzyl-ACM and N-allyl-ACM toward FTase. Like FTase, geranylgeranyl transferase (GGTase) catalyzes the geranylgeranylation of proteins terminating with a CAAX motif, where X is restricted to leucine, isoleucine or phenylalanine. FTase and GGTase have been shown to be heterodimers that share a common a subunit with a different b subunit; therefore, we examined the effect of N-benzyl-ACM and N-allyl-ACM on the inhibitory activity against GGTase and
Novel aclacinomycin derivatives inhibit FTase S Magi et al found that they failed to inhibit GGTase up to 100 mM. Geranylgeranyl pyrophosphate (GGPP) synthase is an enzyme that catalyzed the synthesis of GGPP from isopentenyl pyrophosphate and FPP; thus, because both FTase and GGPP synthase use FPP as a substrate, the effect of N-benzyl-ACM and N-allyl-ACM on GGPP synthase activity was examined. However, neither FTase inhibitor could inhibit GGPP synthase up to 100 mM (Table 2) . So far, although several anthraquinones have been reported as FTase inhibitors, 8, 9 none of the anthracycline family has been identified as an FTase inhibitor; thus, N-benzyl-ACM and N-allyl-ACM are the first examples in a series of the anthracycline family, demonstrating that the compounds inhibit FTase.
Effect of N-benzyl-ACM and N-allyl-ACM on localization of H-Ras
Because N-benzyl-ACM and N-allyl-ACM selectively inhibited FTase in vitro, next we examined whether these compounds could inhibit FTase in a cultured cell system. A431 cells were well-known EGF receptor-overexpressing cells that displayed a sufficient level of H-Ras protein 10 As shown in Figure 3a , the amount of H-Ras in the membrane fraction was not changed in the presence or absence of EGF; however, treatment of cells with N-benzyl-ACM and N-allyl-ACM reduced the amount of H-Ras in the membrane fraction. On the other hand, N-benzyl-ACM and N-allyl-ACM did not affect the geranylgeranylation of Rap1A in the same condition (data not shown). These results suggested that N-benzyl-ACM and N-allyl-ACM inhibited the membrane localization of H-Ras protein through the inhibition of FTase in A431 cells.
Effect of N-benzyl-ACM and N-allyl-ACM on PI3K signaling inhibitors, moverastin A and B, inhibited the PI3K/Akt pathway but not the Raf/MEK/Erk pathway. 5 To confirm whether N-benzyl-ACM or N-allyl-ACM also could inhibit the PI3K pathway selectively, we examined the effect of these compounds on the phosphorylation of Akt or Erk in A431 cells. As shown in Figure 3b , the phosphorylation of Akt (Ser473) was significantly decreased in the presence of either N-benzyl-ACM or N-allyl-ACM, whereas these compounds did not affect the phosphorylation level of Erk. These results suggested that N-benzyl-ACM and N-allyl-ACM inhibited PI3K activation through the suppression of H-Ras farnesylation.
Effect of N-benzyl-ACM and N-allyl-ACM on cell migration Since the activation of H-Ras through the farnesylation by FTase was involved in cell migration, 5 we examined the effect of N-benzyl-ACM or N-allyl-ACM on EGF-induced cell migration in A431 cells. As a result, N-benzyl-ACM or N-allyl-ACM inhibited EGF-induced cell migration in a dose-dependent manner (Figures 4a, b) . These inhibitory effects were not due to the toxic effect of the drugs because their IC 50 values for A431 cell viability were at least seven times higher than those for cell migration (Table 2) . Importantly, the dose of N-benzyl-ACM or N-allyl-ACM required to inhibit cell migration was consistent with that for inhibition of the membrane localization of H-Ras. Moreover, according to the inhibitory activity against FTase, the IC 50 value for the cell migration of N-benzyl-ACM was lower than that of N-allyl-ACM (Table 2) . Neither 10-epi-N-benzyl-ACM nor 10-epi-N-allyl-ACM, which failed to inhibit FTase, suppressed EGFinduced migration of A431 cells (Figure 4c ). Taken together, these findings suggest that N-benzyl-ACM and N-allyl-ACM inhibited the EGF-induced migration of A431 cells by inhibiting H-Ras farnesylation.
